Nanoparticulate Drug Delivery Strategies to Address Intestinal Cytochrome P450 CYP3A4 Metabolism towards Personalized Medicine
Drug dosing in clinical practice, which determines optimal efficacy, toxicity or ineffectiveness, is critical to patients' outcomes. However, many orally administered therapeutic drugs are susceptible to biotransformation by a group of important oxidative enzymes, known as cytochrome P450s (CYP...
Saved in:
Main Authors: | Rui Xue Zhang (Author), Ken Dong (Author), Zhigao Wang (Author), Ruimin Miao (Author), Weijia Lu (Author), Xiao Yu Wu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
by: Hao Wang, et al.
Published: (2020) -
Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes
by: Hannu eRaunio
Published: (2015) -
Isoform CYP1A2, as a part of the cytochrome P450 superfamily
by: Y. G. Novickaya, et al.
Published: (2014) -
Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes
by: Rohitash Jamwal, et al.
Published: (2020) -
An update on the role of intestinal cytochrome P450 enzymes in drug disposition
by: Fang Xie, et al.
Published: (2016)